ICP
CLLS

Interchange Capital Partners’s Cellectis CLLS Stock Holding History

Interchange Capital Partners’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,712
Closed -$235K – 387
2020
Q4 		$235K Buy
+8,712
New +$195K 0.13% 185

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIA
Capital Impact Advisors Boston, Massachusetts $247M AUM 31.15% 1-Year Est. Return

Interchange Capital Partners's CLLS Position: Q1 2021 in Review

Interchange Capital Partners sold out of Cellectis (CLLS) in Q1 2021, closing a stake of 8,712 shares — an estimated $235K sold.

Interchange Capital Partners first reported a position in CLLS in Q4 2020 and held it in 1 quarter. The position peaked at $235K in Q4 2020. 81 funds tracked by Wall St. Rank hold CLLS as of Q1 2021.

  • Interchange Capital Partners reported no remaining Cellectis position as of Q1 2021 after selling out during the quarter.
  • Interchange Capital Partners sold 8,712 Cellectis shares in Q1 2021, an estimated $235K.
  • Interchange Capital Partners first reported a position in Cellectis in Q4 2020 and held it in 1 quarter.
  • Interchange Capital Partners's Cellectis position peaked at $235K in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Cellectis as of Q1 2021.

Based on Interchange Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.